医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

EMS Signs Partnership Agreement with Tellyes for Distribution of Medical Simulation Management Software and Audio-Video Technology in China

2014年10月22日 AM03:52
このエントリーをはてなブックマークに追加


 

EXTON, Pa.

Education Management Solutions (EMS), a pioneer in simulation management technology for healthcare training, and Tellyes Scientific Inc. (Tellyes) today announced a strategic partnership to distribute medical simulation management technology in China.

The agreement between EMS and Tellyes allows the more than 3,000 healthcare-related education institutions in China to benefit from cutting-edge technology for simulation training that will help their learners attain a higher level of mastery than ever before.

According to a recent study, the global healthcare/medical simulation market is poised to grow at a CAGR of 19.6% to reach $1.9 billion by 2017. Education Management Solutions is mentioned in the study as one of the prominent players in the medical simulation space.1 Growth in the Asian market, especially China and India, is expected to boost demand for medical simulation products and services.

“We are excited about this strategic partnership with Tellyes, which will enable EMS to expand its global presence into China,” says Anurag Singh, President and CEO of EMS. “The fact that we will now enter a market with 3,000 medical and nursing universities and 60,000 hospitals together with a leading company in China like Tellyes is a significant step for EMS. Together, we are creating an exciting collaboration with great business potential for both of our companies.”

“This partnership with Education Management Solutions is very important to us,” says Simon Liu, CEO and Chairman of Tellyes. “We are dedicated to the continuum of lifelong healthcare education for our customers and our employees by keeping pace with state-of-the-art technology to expand their knowledge and practices. EMS’ comprehensive solutions will provide the very best in simulation center management software and integrated audio-video recording technology for clinical skills and simulation centers across China. EMS offers the optimum solution for teaching, training, and evaluation of skills performance. This will be a great step forward in medical education in China.”

About Education Management Solutions (EMS)

Education Management Solutions (EMS) is an industry pioneer in simulation-based solutions for healthcare training environments – ranging from clinical simulation management software and hardware to video capture systems, counselor education, case authoring, and virtual computer-based training.

Working alongside subject matter experts, EMS serves as the driving force behind numerous consumer-centered innovations that continue to move the clinical simulation market forward with breakthrough technologies.

As the leader in simulation management technology since its founding in 1994, EMS offers complete turnkey solutions that include integrated software and hardware, design and planning, engineering, configuration, installation, training, file backup, cloud-based eLearning, and support. Visit www.simulationiq.com for more information. Follow EMS on Facebook, LinkedIn, and Twitter.

About Tellyes Scientific

Founded in 1998, Tellyes specializes in the development, manufacture, sales, and service of advanced medical education products. The company has built long-term cooperative relationships with more than 3,000 medical colleges and hospitals and formed numerous collaborations with higher education institutes and research organizations. In addition to the company’s own product line, representation of domestic and foreign companies makes Tellyes one of the leaders in China’s medical education industry. Its well-established distribution network and excellent after-sales service increasingly win the trust and confidence of its clients. Visit http://en.tellyes.com/

1. http://www.marketsandmarkets.com/PressReleases/healthcare-medical-simulation.asp

CONTACT

Education Management Solutions
Dushy Edrisinghe
Director –
Marketing
610-701-7002 x 218

同じカテゴリーの記事 

  • Kolmar BNH, a Top-Tier Korean Enterprise Specializing in the Production of HemoHIM, Dedicates over 2% of its Annual Sales to R&D
  • Takeda公布2023财年全年业绩和2024财年展望,确认对后期研发管线开发和提高核心营业利润率的承诺
  • Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease
  • AMLにおける寛解期に残存するFLT3-ITD変異と移植後の転帰との間に重要な関連があることが研究によって判明
  • 研究表明AML缓解期残留FLT3-ITD突变与移植后结果之间存在重要联系